Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03322046 · ClinicalTrials.gov registry record

Heartmatters Challenge - First Responders

A clinical trial of Cardiovascular Diseases, sponsored by Boston Heart Diagnostics.

Completed
Registry status
185
Enrollment target
1
Study location

NCT03322046 is a study of Cardiovascular Diseases that has completed, run by Boston Heart Diagnostics. The registered enrollment target is 185 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03322046, a study of Cardiovascular Diseases, has completed, sponsored by Boston Heart Diagnostics.

COMPLETED
Registry status
185 participants
Enrollment target
1
Study location

Study Summary

The purpose of this protocol is to observe whether providing the first responder population with a multi-tiered therapeutic lifestyle modification program, including regular blood testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools and smartphone apps can lead to positive changes in behavior, resulting in improvements in blood based markers of risk of cardiovascular disease (CVD) as well as improvements in weight and waist circumference.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle Program

Study Locations (1)

Massachusetts

  • Boston Heart Diagnostics - Framingham

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2013-10-08
Est. Completion 2015-01-08

Sponsor

Boston Heart Diagnostics

1 total trials

What the Registry Record Tells You About NCT03322046

The ClinicalTrials.gov registry entry for NCT03322046 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Boston Heart Diagnostics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Program is the first listed.

NCT03322046 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03322046 about?

NCT03322046 is a clinical study titled "Heartmatters Challenge - First Responders". The purpose of this protocol is to observe whether providing the first responder population with a multi-tiered therapeutic lifestyle modification program, including regular blood testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools and smartphone apps can lea...

What is the current status of trial NCT03322046?

This trial is currently completed. The enrollment target is 185 participants. The study started on 2013-10-08. Estimated completion is 2015-01-08.

What conditions does trial NCT03322046 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT03322046?

The interventions under investigation include: Lifestyle Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03322046?

This trial is sponsored by Boston Heart Diagnostics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03322046 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.